Mutating novel interaction sites in NRP1 reduces SARS-CoV-2 spike protein internalization
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
The global pandemic of Coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 has become a severe global health problem because of its rapid spread( 1 ). Both angiotensin-converting enzyme 2 and neuropilin 1 provide initial viral binding sites for SARS-CoV-2 ( 2, 3 ). Here, we show that three cysteine residues located in a1/a2 and b1 domains of neuropilin 1 are necessary for SARS-CoV-2 spike protein internalization in human cells. Mutating cysteines C82, C104 and C147 altered neuropilin 1 stability and binding ability as well as cellular internalization and lysosomal translocation of the spike protein. This resulted in up to 4 times reduction in spike protein load in cells for the original, alpha and delta SARS-CoV-2 variants even in the presence of the endogenous angiotensin-converting enzyme 2 receptor. Transcriptome analysis of cells transfected with mutated NRP1 revealed significantly reduced expression of genes involved in viral infection and replication, including eight members of the ribosomal protein L, ten members of ribosomal protein S and five members of the proteasome β subunit family proteins. We also observed higher expression of genes involved in suppression of inflammation and endoplasmic reticulum associated degradation. These observations suggest that these cysteines offer viable targets for therapies against COVID-19.
Article activity feed
-
SciScore for 10.1101/2021.10.11.463689: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics not detected. Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources HA antibody (HA.C5 #18181; 1:1000) and LAMP1 antibody (#24170) were purchased from Abcam. LAMP1suggested: (Abcam Cat# ab24170, RRID:AB_775978)M2 anti Flag Mouse antibody (#SLBT7654; 1:5000) and Actin (#087M4850; 1:10,000) were purchased from Sigma. M2 anti Flag Mouse antibody (#SLBT7654; 1:5000)suggested: Noneanti Flag Mouse antibodysuggested: NoneActinsuggested: NoneExperimental Models: Cell Lines Sentences Resources Mammalian cell culture, transfection, and drug treatment: HeLa and HEK … SciScore for 10.1101/2021.10.11.463689: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics not detected. Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources HA antibody (HA.C5 #18181; 1:1000) and LAMP1 antibody (#24170) were purchased from Abcam. LAMP1suggested: (Abcam Cat# ab24170, RRID:AB_775978)M2 anti Flag Mouse antibody (#SLBT7654; 1:5000) and Actin (#087M4850; 1:10,000) were purchased from Sigma. M2 anti Flag Mouse antibody (#SLBT7654; 1:5000)suggested: Noneanti Flag Mouse antibodysuggested: NoneActinsuggested: NoneExperimental Models: Cell Lines Sentences Resources Mammalian cell culture, transfection, and drug treatment: HeLa and HEK 293T cells were obtained from ATCC and maintained in a humidified atmosphere at 5% CO2 in Dulbecco’s Modified Eagle’s (DMEM) complete medium (Corning) supplemented with 10% fetal bovine serum (FBS; Seradigm) in 37°C. HeLasuggested: NoneWestern Blotting and immunoprecipitation: For immunoprecipitation, either HA-tagged NRP1 (or mutants) and Flag-tagged SARS-CoV-2-S (or S1493-685) mutant or HA-tagged NRP1 (or mutants) and Flag-Plexin-A1 were expressed where indicated in 293T cells for 30 hours. 293Tsuggested: NoneRNA-seq analysis: For RNA-seq analysis, Total RNA was extracted from HEK293T cell line 30 hours post transfection (HA-NRP1 and SARS-CoV-2-S1493-685 and or HA-NRP1-4Cys-4Ala and SARS-CoV-2-S1493-685) using TRIzol reagent (Invitrogen) according to the manufacturer’s instructions. HEK293Tsuggested: NoneRecombinant DNA Sentences Resources Plasmids and recombinant proteins: HA-NRP1 and different mutants of HA-NRP1, Flag-Plexin-A1, Flag-SARS-CoV-2-S-original (NC_045512.2), Flag-SARS-CoV-2-B.1.1.7-S, Flag-SARS-CoV-B.1.351-S were all obtained from GenScript (Cloned into pcDNA 3.1 vector). pcDNA 3.1suggested: RRID:Addgene_20407)For cycloheximide stability assay, 293T cells were transfected with the constructs encoding HA-NRP1 or HA-NRP1 mutants. HA-NRP1suggested: NoneSoftware and Algorithms Sentences Resources The PAN domain coordinates from Uniprot were used to extract the PAN domain sequences from the full-length proteins which were then aligned with MAFFT linsi(54). MAFFTsuggested: (MAFFT, RRID:SCR_011811)The alignment was visualized with Geneious. Geneioussuggested: (Geneious, RRID:SCR_010519)The raw RNA-seq reads have been deposited at NCBI under BioProject ID PRJNA767890. BioProjectsuggested: (NCBI BioProject, RRID:SCR_004801)Reads were mapped with bowtie2 v2.2.5. (55). bowtie2suggested: (Bowtie 2, RRID:SCR_016368)Differential expression analysis was performed with DESeq2, genes with an adjusted p-value less than 0.05 were considered differentially expressed (56). DESeq2suggested: (DESeq, RRID:SCR_000154)Statistical analysis: Statistical analyses were performed on individual experiments, as indicated, with GraphPad Prism 8 Software using an unpaired t-Test, equal variance for comparison between two groups and one-way ANOVA for comparisons between more than two groups. GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-